Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma.
Saved in:
| Title: | Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma. |
|---|---|
| Authors: | Lee H; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Ahn S; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Gonzales GA; Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada., Leblay N; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Barakat E; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Greening D; Department of Physiology and Pharmacology and the Live Cell Imaging Laboratory, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada., Colarusso P; Department of Physiology and Pharmacology and the Live Cell Imaging Laboratory, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada., Canton J; Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada., Benaoudia S; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Hasheminasabgorji E; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Poorebrahim M; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Jung D; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Truger M; MLL Munich Leukemia Laboratory, Munich, Germany., Jeong J; Department of Life Science, Pohang University of Science and Technology, Pohang, South Korea., Riedhammer C; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany., Einsele H; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany., Kortüm KM; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany., Eckmann J; Discovery Oncology, Roche Pharma Research and Early Development, Roche Innovation Center, Munich, Germany., Somandin J; Roche Innovation Center Zurich, Roche Pharma Research and Early Development (pRED), Schlieren, Switzerland., Engel SS; Laboratory for Hematological Diagnostics, MVZ, Heppenheim, Germany., Boise LH; Department of Hematology and Medical Oncology, Emory School of Medicine, and the Winship, Cancer Institute of Emory University Atlanta, Atlanta, GA, USA., Frenking JH; Heidelberg Myeloma Center, Department of Medicine V, Heidelberg University Hospital and Medical Faculty, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Weinhold N; Heidelberg Myeloma Center, Department of Medicine V, Heidelberg University Hospital and Medical Faculty, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Taouxi K; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Skerget S; Johnson & Johnson, Spring House, PA, USA., Vishwamitra D; Johnson & Johnson, Spring House, PA, USA., Cho Y; Department of Life Science, Pohang University of Science and Technology, Pohang, South Korea., Maura F; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Raab MS; Heidelberg Myeloma Center, Department of Medicine V, Heidelberg University Hospital and Medical Faculty, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Corre J; University of Toulouse, University Hospital, Unit for Genomics in Myeloma, IUCT Oncopole, CRCT, Toulouse, France., Rasche L; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany., Avet-Loiseau H; Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France., Neri P; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada. nbahlis@ucalgary.ca. |
| Source: | Nature medicine [Nat Med] 2026 Mar; Vol. 32 (3), pp. 964-977. Date of Electronic Publication: 2026 Jan 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41540108 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lee+H%22">Lee H</searchLink>; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Ahn+S%22">Ahn S</searchLink>; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Gonzales+GA%22">Gonzales GA</searchLink>; Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Leblay+N%22">Leblay N</searchLink>; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Barakat+E%22">Barakat E</searchLink>; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Greening+D%22">Greening D</searchLink>; Department of Physiology and Pharmacology and the Live Cell Imaging Laboratory, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Colarusso+P%22">Colarusso P</searchLink>; Department of Physiology and Pharmacology and the Live Cell Imaging Laboratory, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Canton+J%22">Canton J</searchLink>; Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Benaoudia+S%22">Benaoudia S</searchLink>; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Hasheminasabgorji+E%22">Hasheminasabgorji E</searchLink>; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Poorebrahim+M%22">Poorebrahim M</searchLink>; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Jung+D%22">Jung D</searchLink>; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Truger+M%22">Truger M</searchLink>; MLL Munich Leukemia Laboratory, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Jeong+J%22">Jeong J</searchLink>; Department of Life Science, Pohang University of Science and Technology, Pohang, South Korea.<br /><searchLink fieldCode="AU" term="%22Riedhammer+C%22">Riedhammer C</searchLink>; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Einsele+H%22">Einsele H</searchLink>; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kortüm+KM%22">Kortüm KM</searchLink>; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Eckmann+J%22">Eckmann J</searchLink>; Discovery Oncology, Roche Pharma Research and Early Development, Roche Innovation Center, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Somandin+J%22">Somandin J</searchLink>; Roche Innovation Center Zurich, Roche Pharma Research and Early Development (pRED), Schlieren, Switzerland.<br /><searchLink fieldCode="AU" term="%22Engel+SS%22">Engel SS</searchLink>; Laboratory for Hematological Diagnostics, MVZ, Heppenheim, Germany.<br /><searchLink fieldCode="AU" term="%22Boise+LH%22">Boise LH</searchLink>; Department of Hematology and Medical Oncology, Emory School of Medicine, and the Winship, Cancer Institute of Emory University Atlanta, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Frenking+JH%22">Frenking JH</searchLink>; Heidelberg Myeloma Center, Department of Medicine V, Heidelberg University Hospital and Medical Faculty, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Weinhold+N%22">Weinhold N</searchLink>; Heidelberg Myeloma Center, Department of Medicine V, Heidelberg University Hospital and Medical Faculty, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Taouxi+K%22">Taouxi K</searchLink>; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Kastritis+E%22">Kastritis E</searchLink>; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Skerget+S%22">Skerget S</searchLink>; Johnson & Johnson, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Vishwamitra+D%22">Vishwamitra D</searchLink>; Johnson & Johnson, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Cho+Y%22">Cho Y</searchLink>; Department of Life Science, Pohang University of Science and Technology, Pohang, South Korea.<br /><searchLink fieldCode="AU" term="%22Maura+F%22">Maura F</searchLink>; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Raab+MS%22">Raab MS</searchLink>; Heidelberg Myeloma Center, Department of Medicine V, Heidelberg University Hospital and Medical Faculty, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Corre+J%22">Corre J</searchLink>; University of Toulouse, University Hospital, Unit for Genomics in Myeloma, IUCT Oncopole, CRCT, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Rasche+L%22">Rasche L</searchLink>; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Avet-Loiseau+H%22">Avet-Loiseau H</searchLink>; Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Neri+P%22">Neri P</searchLink>; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Bahlis+NJ%22">Bahlis NJ</searchLink>; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada. nbahlis@ucalgary.ca. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2026 Mar; Vol. 32 (3), pp. 964-977. <i>Date of Electronic Publication: </i>2026 Jan 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41540108 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41591-025-04175-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 964 Titles: – TitleFull: Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lee H – PersonEntity: Name: NameFull: Ahn S – PersonEntity: Name: NameFull: Gonzales GA – PersonEntity: Name: NameFull: Leblay N – PersonEntity: Name: NameFull: Barakat E – PersonEntity: Name: NameFull: Greening D – PersonEntity: Name: NameFull: Colarusso P – PersonEntity: Name: NameFull: Canton J – PersonEntity: Name: NameFull: Benaoudia S – PersonEntity: Name: NameFull: Hasheminasabgorji E – PersonEntity: Name: NameFull: Poorebrahim M – PersonEntity: Name: NameFull: Jung D – PersonEntity: Name: NameFull: Truger M – PersonEntity: Name: NameFull: Jeong J – PersonEntity: Name: NameFull: Riedhammer C – PersonEntity: Name: NameFull: Einsele H – PersonEntity: Name: NameFull: Kortüm KM – PersonEntity: Name: NameFull: Eckmann J – PersonEntity: Name: NameFull: Somandin J – PersonEntity: Name: NameFull: Engel SS – PersonEntity: Name: NameFull: Boise LH – PersonEntity: Name: NameFull: Frenking JH – PersonEntity: Name: NameFull: Weinhold N – PersonEntity: Name: NameFull: Taouxi K – PersonEntity: Name: NameFull: Kastritis E – PersonEntity: Name: NameFull: Skerget S – PersonEntity: Name: NameFull: Vishwamitra D – PersonEntity: Name: NameFull: Cho Y – PersonEntity: Name: NameFull: Maura F – PersonEntity: Name: NameFull: Raab MS – PersonEntity: Name: NameFull: Corre J – PersonEntity: Name: NameFull: Rasche L – PersonEntity: Name: NameFull: Avet-Loiseau H – PersonEntity: Name: NameFull: Neri P – PersonEntity: Name: NameFull: Bahlis NJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2026 Mar Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1546-170X Numbering: – Type: volume Value: 32 – Type: issue Value: 3 Titles: – TitleFull: Nature medicine Type: main |
| ResultId | 1 |